BioCentury
ARTICLE | Clinical News

Immunocore preclinical data

May 14, 2012 7:00 AM UTC

In a mouse xenograft model of melanoma, once-daily 0.1, 0.04 and 0.01 mg/kg IV ImmTAC-gp100 for 4 days significantly inhibited tumor growth at day 8 through day 32 vs. vehicle-treated controls (p<0.01...